Greater Baltimore Committee awards three CEOs and university president at 2008 Baltimore Region Bioscience Awards Ceremony

Three biotech CEOs and the president of one of the area’s major research universities were honored today by the Greater Baltimore Committee as winners of the region’s third bioscience award competition.

Winners of the 2008 Greater Baltimore Region Bioscience Awards are:

  • Best New Product or Progress: Timothy E. Askew, president and CEO, CSA Medical, Inc. Askew’s very young Baltimore-based company has developed a breakthrough product incorporating a new medical device and use of liquid nitrogen cryo-therapy treatment to literally freeze cancer tissue. The CSA system has been successful in treating esophageal cancer and Barrett’s esophagus, a condition that often progresses to esophageal cancer.
  • Entrepreneurship: Dr. Julie D. Suman, co-founder & president, Next Breath, LLC. Suman’s five-year-old company, Next Breath, provides contract services to pharmaceutical, biotech and medical device companies that bring new inhalation and nasal products to market. Located at the UMBC incubator in southwest Baltimore County, Next Breath provides services to support the drug development efforts of 45 pharmaceutical companies in the U.S., Canada, Europe and India.
  • Leadership in Bioscience: Dr. Blake M. Paterson, CEO and co-founder, Alba Therapeutics Corporation. Under the leadership of Paterson, Alba Therapeutics has grown in four years from a two-person start-up at the Emerging Technologies Center in Baltimore into a thriving biotechnology company with 45 employees at its headquarters at the University of Maryland, BioPark. Alba is a pioneer in the treatment of Celiac disease, an autoimmune disorder.
  • President’s Award: Dr. David J. Ramsay, president, University of Maryland, Baltimore. Dr. Ramsay has championed the growth of biomedical research and technology transfer at UMB, where biotech research has grown by 500 percent since 1994. Ramsay has been the driving force behind the development of the UMB BioPark in west Baltimore. During the last five years, the park has grown to 340,000 square feet of research space and 200 biotech jobs. This year, another 300,000 square feet and 150 more jobs will be added.

Approximately 150 leaders from the Baltimore region’s bioscience industry and research community attended the awards presentations at the Renaissance Harborplace Hotel.

“The most important thing that the Greater Baltimore Committee can do is to listen to the voices of individual companies, owners, and researchers – and find the best ways to support and celebrate the work that you do every day,” GBC president and CEO Donald C. Fry told the bioscience researchers, entrepreneurs and advocates.

Nurturing development of the region’s bioscience industry is a top priority of the GBC, the region’s most prominent organization of business and civic leaders.

Winners of the 2008 Greater Baltimore Region Bioscience Awards were selected by a panel of judges from among 22 nominees submitted by businesses, bioscience advocates, higher education institutions and government agencies.

Judges for this year’s awards were: Dr. Ravinder Dhallan, chairman and CEO, Ravgen; Steve Dubin, chief executive officer, Martek Biosciences Corporation; Dr. Aaron H. Heifetz, vice president, business development, Cognate BioServices, Inc.; James Hughes, vice president, research and development, University of Maryland, Baltimore; Dr. Shira Kramer, president, Sterilex Corporation; and Mark E. Rapson, CPA, shareholder and leader, Health & Life Science Group, KAWG&F.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.
_________________________________________________________________________________________________________________________

Photo Gallery

Comments are closed.